Company
senti
Developing differentiated cancer therapeutics
Also known as Senti Bio, Senti Biosciences, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Legal name
- Senti Biosciences, Inc.
- sentibio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Senti Bio is a clinical-stage company developing a new generation of cell and gene therapies for patients living with incurable diseases.
Funding snapshot
- Total raised
- $47.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10M2026-05-20
Funding rounds
- Round, 2026
- $10M2026-05-20, SEC form D sold, 1 investor
- Round, 2024
- $37.6M2024-12-09, SEC form D sold, 15 investors
Products
- Other
- SENTI-202
Loading relationship preview